Skip to content
AusGrant
Federal Closing soon GRANTS-GOV-362197

DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award

Defense Health Agency Contracting Activity - DHACA (DOD) · Competitive · Science & Technology

At a glance

DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award is a federal competitive grant from Defense Health Agency Contracting Activity - DHACA for the science & technology sector. Funding is up to $2K. Eligible applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility". The application deadline is September 30, 2026. Apply via the official listing at www.grants.gov.

Amount
Up to $2K
Deadline
Sep 30, 2026
Type
Competitive
Status
Closing soon

About this program

Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Idea Award (TIA) supports new, innovative, high-risk, high-gain ideas aimed at amyotrophic lateral sclerosis (ALS) drug or therapy discovery. The studies supported by this award mechanism are expected to be hypothesis-driven and generate preliminary data for future avenues of therapeutic investigation.Distinctive Features: Potential impact and innovation are important features of the TIA. Applications may demonstrate the ability to achieve interpretable results in the absence of preliminary data supporting the hypothesis. While the inclusion of preliminary data is not prohibited, the strength of the application should rely on the approach.

Who can apply

Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

How to apply

Apply through Grants.gov using funding opportunity number HT942526ALSRPTIA. Register your organization (SAM.gov + Grants.gov) before the deadline, then submit the application package listed in the official notice.

Apply at official source